Please assess the completion status of the following clinical trial:

Trial Title: Neuromuscular Blocking Agents in the Elderly

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients \> 18 years old~* Informed consent~* Scheduled for elective surgery (\>1 hour) under general anaesthesia with intubation and use of rocuronium.~* American Society of Anaesthesiologists (ASA) physical status classification I to III~* Can read and understand Danish~Exclusion Criteria:~* Known allergy to rocuronium~* Neuromuscular disease that may interfere with neuromuscular data~* Indication for rapid sequence induction

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Elderly (>80 years) (Type: None): Patients planned for elective surgery above 80 years
- Younger (18-40 years) (Type: None): Patients planned for elective surgery between 18-40 years

Based on this trial design, predict the completion outcome and termination type (if applicable).